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umerous studies have suggested a link between Parkinson’s
disease (PD) and pesticide exposure,
1 particularly to rote-
none and paraquat, two naturally occurring organic pesticides.
A recently reported nested case-control study demonstrated a
2.5-fold increase in the relative risk of developing PD among
farmers exposed to either rotenone or paraquat.
2 Although both
pesticides are mitochondrial toxins, they appear to have distinct
toxicological mechanisms.
3,4 The focus of this rapid report is on
how rotenone aﬀects central metabolic pathways in the cell.
RotenoneisknowntobindtocomplexIoftheelectrontransport
chain, preventing the transfer of electrons from iron sulfur
clusters to ubiquinone,
5 reducing oxidative phosphorylation,
and generating reactive oxygen species (ROS).
6 Chronic low
dose administration of rotenone to rats causes selective nigros-
triatal degeneration and formation of α-synuclein-positive cyto-
plasmic inclusions, similar to Lewy bodies, in nigral dopa-
minergic neurons. This results in neurodegenerative features
that are comparable to those seen in PD,
7,8 although the exact
mechanism involved in rotenone mediated-neurotoxicity re-
mains unclear.
The majority of recent research on rotenone toxicity has
focusedoncomplexIinhibitionandROSformation.
5,9However,
rotenone has eﬀects that are independent of complex I inhibi-
tion,
10 which signiﬁcantly alters cellular metabolism, including
changesinanumberof intermediatesandend-productsof major
bioenergetic pathways.
11,12 Technological developments in both
mass spectrometry (MS) and NMR have produced a growing
number of metabolomic assays to assess changes in intracellular
and extracellular metabolites.
1315 In this study, we further
explored metabolic changes induced by rotenone by analyzing
its eﬀects on intracellular levels of various short chain acyl-CoA
thioesters, which are known to be involved in a number of
metabolic pathways.
16 This was accomplished using stable
isotope dilution liquid chromatography (LC)-MS, which pro-
vides the most speciﬁc methodology for rigorous quantiﬁcation
of biomarkers and endogenous metabolites.
17 Stable isotope
labeling by essential nutrients in cell culture (SILEC), a tech-
nique in which cells are grown in the presence of [
13C3
15N1]-
pantothenate (a CoA precursor), was used to generate isotopi-
cally labeled short chain acyl-CoA thioesters.
18,19 The extracted
labeled CoA species were used as stable isotope internal stan-
dards in LC-selected reaction monitoring (SRM)/MS analyses
toquantifychangesinintracellularlevelsofshortchainacyl-CoA
species caused by subcytotoxic doses of rotenone in various
humancelllines,includingneuroblastoma(SH-SY5Y),hepato-
cellular carcinoma (HepG2), and bronchoalveolar carcinoma
(H358) cells. To further characterize the temporal nature of
these changes in a neuronal cell type, a time course study was
performed in the SH-SY5Y cell line. Finally, isotopomer analysis
using [U-
13C6]-glucose was performed in SH-SY5Y cells in the
presence or absence of rotenone.
Rotenonewasfoundtoinducedose-dependentchangesinthe
short chain acyl-CoA proﬁles of SH-SY5Y, HepG2, and H358
cells. Most notably, there was a signiﬁcant decrease in levels of
succinyl-CoA (Figure 1A) and a concomitant increase in β-
hydroxybutyryl (BHB)-CoA (Figure 1B) after 1 h of treatment
with an IC50 of <100 nM in all cell types. There were also
signiﬁcant changes in a number of other acyl-CoA thioesters,
whichvariedamongdiﬀerentcelltypes(SupportingInformation,
Table 1). To characterize the temporal nature of these changes,
SH-SY5Ycellsweretreatedwith100nMrotenoneandharvested
at time points up to 6 h and analyzed for CoA thioesters. The
observed changes seen in succinyl-CoA and BHB-CoA persisted
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decrease in succinyl-coenzyme A (CoA) and increase in β-hydroxybutyryl-CoA in
multiple human cell lines (IC50 < 100 nM). Rotenone also inhibited [U-
13C6]-glucose-
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toma cells. These changes are compatible with a compensatory metabolic rearrange-
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thioester isotopomer analysis provided insight into mechanisms of rotenone toxicity,
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for at least 6 h (Figure 1C). Overall, these results show that
rotenoneinducesarapidandpersistentmetabolicrearrangement
in a variety of cell types, similar to changes observed during
fasting.
20
Althoughtheobservedchangesindicatethatrotenoneinduces
a signiﬁcant metabolic disturbance, absolute CoA measurements
represent only a snapshot of this metabolic state. To gain
additional information on the cumulative ﬂux through diﬀerent
pathways, cells were incubated with [U-
13C6]-glucose, and
isotopomer distribution of the resulting CoA derivatives was
analyzed. [U-
13C6]-glucose (M6) taken up by cells is converted
during glycolysis into two [
13C3]-pyruvates (M3), which can be
converted by pyruvate dehydrogenase (PDH) into [
13C2]-acet-
yl-CoA(M2).Bothlabeledcarbonsfromacetyl-CoAcanthenbe
incorporated into citrate and eventually form [
13C2]-succinyl-
CoA (M2) in the ﬁrst turn of the Krebs cycle. Additional cycles
canresultintheM3andM4succinyl-CoAisotopomers.Itshould
be noted that isotopic tracer analysis is complex, with numerous
intersectingmetabolicpathways.Forourpurposes,however,this
simpliﬁedinterpretationmadeitpossibletoassessmajorchanges
that were occurring in the cells. SH-SY5Y cells were washed and
treated with glucose-free media supplemented with either un-
labeled glucose or [U-
13C6]-glucose with or without 100 nM
rotenone. The unlabeled cells were used to determine isotopic
contributions of unlabeled CoA species to each isotopomer,
which were subtracted from the labeled CoA species using a
matrix analysis.
21
Rotenone signiﬁcantly decreased the incorporation of glu-
cose-derivedcarbonatomsintoacetyl-CoA,from23%to5%,de-
monstrating that rotenone inhibited the glucose-derived biosynthesis
of acetyl-CoA (Figure 2). Interestingly, while there was a decrease in
the % labeled acetyl-CoA (Figure 2), the overall concentration of
acetyl-CoA did not change signiﬁcantly (Supporting Information,
Table 1). Rotenone also signiﬁcantly decreased the M2, M3, and M4
isotopomers of succinyl-CoA, indicating decreased conversion of
glucosetosuccinyl-CoA.Therefore,thedecreaseinabsolutesuccinyl-
CoA concentrations was due, in part, to decreased glucose-derived
ﬂux through the Krebs cycle (Figure 2). Lastly, there was no isotopic
labeling of CoASH, conﬁrming that the labeling occurred only in the
acyl moiety.
In this study, we have shown for the ﬁrst time that rotenone
not only inhibits glucose-derived formation of both acetyl-CoA
andsuccinyl-CoAbutalsoinducesanincreaseintheformationof
BHB-CoA in a number of human cell lines. Increased ROS and
NADH/NAD
+ratioresultingfromrotenone-mediatedcomplexI
inhibitionwoulddecreasePDHactivity,
22explainingthedecrease
inacetyl-CoAlabeling.Thisisconsistentwitharecentﬁndingthat
rotenone causes increased shunting of glycolytic intermediates
into lactate.
11 The absence of a decrease in the absolute concen-
trationofacetyl-CoAindicateseitheranalternatesourceofacetyl-
CoA or an inhibition of acetyl-CoA utilization.
Thedecreaseinsuccinyl-CoAlevelsisconsistentwitharecent
study in Arabidopsis cells, in which a rapid 50% decrease in α-
ketoglutarate, the precursor of succinyl-CoA (Figure 2), was
observed after 1 h of rotenone treatment.
12 This may be, in part,
due to an inhibition of aconitase, which is known to be inhibited
by rotenone and ROS formation.
23,24 The dramatic decrease in
intracellular succinyl-CoA (Figure 1A) would cause decreased
protein succinylation, a post-translational modiﬁcationwithimpor-
tant regulatory implications. For example, 3-hydroxy-3-methyl-
glutaryl (HMG)-CoA synthase, the rate-determining enzyme in
Figure 1. Rotenone-mediated changes in intracellular CoA thioester
levels. (A) Succinyl-CoA. (B) BHB-CoA extracted from SH-SY5Y cells,
HepG2 cells, and H358 cells treated with rotenone for 1 h, in triplicate.
Values are shown as % of the maximal level for each cell line. (C) Time
course of rotenone-mediated changes in intracellular succinyl-CoA and
BHB-CoA. SH-SY5Y cells were treated with 100 nM rotenone, har-
vestedattimepointsupto6h,andprocessedforCoAs.Errorbarsshow
SEMs for triplicate determinations.
Figure 2. Eﬀect of rotenone on the biosynthesis of glucose-derived
acetyl-CoA and succinyl-CoA. SH-SY5Y cells were incubated in media
containing [U-
13C6]-glucose and 100 nM rotenone or DMSO (vehicle)
for 6 h. Isotopomer distributions are shown in relation to the Krebs
cycle.ErrorbarsareSEMsforn=5,*p<0.05comparedwiththeDMSO
vehicle.1632 dx.doi.org/10.1021/tx200366j |Chem. Res. Toxicol. 2011, 24, 1630–1632
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ketogenesis is inactivated by succinylation, which is, in turn, regu-
latedbysuccinyl-CoAconcentrations.
25Inaddition,arecentstudy
has shown that succinylation of lysine residues occurs as a post-
translational regulatory modiﬁcation to certain enzymes such as
isocitrate dehydrogenase.
26
The rotenone-mediated increase in BHB-CoA (Figure 1B), to-
gether with the minimal incorporation of [U-
13C6]-glucose into
BHB-CoA (<5%) is indicative of a compensatory metabolic rearran-
gement. Speciﬁcally, BHB-CoA formed by increased fatty acid β-
oxidation,
27 could be metabolized by 3-hydroxyacyl-CoA dehydro-
genase to form acetoacetyl-CoA,
28 followed by thiolase (ACAT1)-
mediated formation of acetyl-CoA.
29 This would allow the cell to
maintain cellular bioenergetics while bypassing the inhibition of
glucose-derivedacetyl-CoA.Whetherthesechangesareapathological
result of rotenone toxicity, or whether they represent a physiological
compensationbyknownorunknownmetabolicpathways,remainsto
be determined. However, the prolonged reliance on compensatory
pathwayscouldplayanimportantroleinrotenonetoxicityinvivodue
to diﬀerences in the abilities of diﬀerent tissues or cell types to up-
regulate or maintain these metabolic rearrangements.
In summary, we have shown that SILEC-based stable isotope
dilution LC-MS methodology coupled with isotopomer analysis
of CoA thioesters can be used in vitro to gain insight into the
mechanisms involved in the toxicity of environmental agents
such as rotenone. This methodology will also make it possible to
further explore the role of mitochondrial dysfunction in meta-
bolic and neurodegenerative diseases.
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